Previous 10 | Next 10 |
2024-02-16 16:37:46 ET Gainers: Iovance Biotherapeutics ( IOVA ) +4% . Microvision ( MVIS ) +3% . Iridium Communications ( IRDM ) +3% . Playtika Holding ( PLTK ) +2% . JetBlue Airways ( JBLU ) +2% . Losers...
EMERYVILLE, Calif., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that it is now preparing to launch the Phase 2b head-to-head trial of its next-generation CO...
2024-02-09 16:51:46 ET Gainers: Amtech Systems ( ASYS ) +7% . Oportun Financial ( OPRT ) +5% . Nutanix ( NTNX ) +3% . Gritstone bio ( GRTS ) +2% . Grifols ( GRFS ) +2% . Losers: Applied Blockchain ( APLD ) -10% . ...
EMERYVILLE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that management will be participating in the following investor conference: B. ...
2024-01-12 16:40:04 ET Gainers: Outset Medical ( OM ) +11% . Kandi Technologies Group ( KNDI ) +7% . Dyne Therapeutics ( DYN ) +5% . Revance Therapeutics ( RVNC ) +4% . NovoCure Limited ( NVCR ) +3% . Losers: Gritstone...
2024-01-05 16:47:44 ET Gainers: Credo Technology Group Holding ( CRDO ) +3% . Gritstone ( GRTS ) +3% . PetMed Express ( PETS ) +3% . Navitas Semiconductor Corporation ( NVTS ) +2% . Intuitive Machines ( LUNR ) +2% . ...
2024-01-03 06:07:32 ET Summary Gritstone bio's strength lies in its best-in-class antigen prediction driven by its proprietary AI platform called EDGE. The company employs next-generation vectors, including ChAd and samRNA, to induce strong and durable immune responses. Gritst...
2023-11-08 17:14:33 ET More on Gritstone bio Gritstone bio: Renewed Excitement For Its COVID-19 Vaccine Gritstone bio (GRTS) Investor Presentation - Slideshow Jones starts Gritstone at buy; cites cancer, COVID-19 vaccines Gritstone shares rally on BARDA contr...
-- BARDA contract and IDWeek presentations position Gritstone’s self-amplifying mRNA (samRNA) as a leading next-generation approach to COVID-19 prevention; preparations underway for Phase 2b head-to-head study evaluating samRNA candidate versus an approved COVID-19 vaccine -- -- ...
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
News, Short Squeeze, Breakout and More Instantly...
Gritstone Oncology Inc. Company Name:
GRTS Stock Symbol:
NASDAQ Market:
Gritstone Oncology Inc. Website:
2024-06-14 13:15:03 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for GRTS on June 14, 2024 11:01AM ET. The previous analyst recommendation was Market Outperform. GRTS was trading at $0.7575 at issue of the analyst recommendation. The overall analyst ...
2024-05-24 11:30:04 ET B. Riley analyst issues BUY recommendation for GRTS on May 24, 2024 09:31AM ET. The previous analyst recommendation was Buy. GRTS was trading at $0.8039 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
-- Favorable progression-free survival (PFS) trend observed in preliminary data from the randomized Phase 2 study evaluating GRANITE (personalized neoantigen vaccine) in front-line metastatic, microsatellite-stable colorectal cancer (MSS-CRC); mature PFS data expected in the third quarter of 2024...